BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 38437053)

  • 1. Glycemic control in medical inpatients with type 2 diabetes mellitus receiving sliding scale insulin regimens versus routine diabetes medications: a multicenter randomized controlled trial.
    Dickerson LM; Ye X; Sack JL; Hueston WJ
    Ann Fam Med; 2003; 1(1):29-35. PubMed ID: 15043177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Role of Injectable Medications in Type 2 Diabetes Treatment.
    Miller EM
    J Fam Pract; 2017 Oct; 66(10 Suppl):S4-S6. PubMed ID: 28991930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of non-insulin diabetes medicines after insulin initiation: A retrospective cohort study.
    Xu Y; Pilla SJ; Alexander GC; Murimi IB
    PLoS One; 2019; 14(2):e0211820. PubMed ID: 30759121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-insulin Medications for the Management of Type 2 Diabetes.
    Home Healthc Now; 2024 Mar-Apr 01; 42(2):E2. PubMed ID: 38437053
    [No Abstract]   [Full Text] [Related]  

  • 5. Protein Tyrosine Phosphatase 1B Inhibitors: A Novel Therapeutic Strategy for the Management of type 2 Diabetes Mellitus.
    Prabhakar PK; Sivakumar PM
    Curr Pharm Des; 2019; 25(23):2526-2539. PubMed ID: 31333090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of bolus insulin and advancing insulin therapy in type 2 diabetes.
    Karl DM
    Curr Diab Rep; 2004 Oct; 4(5):352-7. PubMed ID: 15461900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The continuation of oral medications with the initiation of insulin therapy in type 2 diabetes: a review of the evidence.
    McFarland MS; Knight TN; Brown A; Thomas J
    South Med J; 2010 Jan; 103(1):58-65. PubMed ID: 19996858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of new agents in the treatment of type 2 diabetes.
    Zimmerman BR; Hagen MD
    J Fam Pract; 1998 Nov; 47(5 Suppl):S37-43. PubMed ID: 9834754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
    Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS
    Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulins and oral hypoglycemic medications.
    Hale DE; Kiess W
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():153-62. PubMed ID: 16456494
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.